DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
LIDOFLAZINE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
LIDOFLAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
J4ZHN3HBTE
Molecule Type:
Small molecule
Molecular Formula:
C30H35F2N3O
Molecular Weight:
491.63
AlogP:
5.75
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
9.0
Source:
NAFTAZONE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
NAFTAZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
15B0523P5L
Molecule Type:
Small molecule
Molecular Formula:
C11H9N3O2
Molecular Weight:
215.21
AlogP:
0.92
PSA:
84.55
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PARECOXIB
4
Small molecule
Approved
Unknown
Unknown
Shoulder Pain; Pain; Renal Colic; Rib Fractures; Pain, Postoperative; Rheumatic Diseases
Cyclooxygenase-2 inhibitor
PARECOXIB
×
Maximum Phase:
4
First Approval:
None
UNII:
9TUW81Y3CE
Molecule Type:
Small molecule
Molecular Formula:
C19H18N2O4S
Molecular Weight:
370.43
AlogP:
3.53
PSA:
89.27
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DISTIGMINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Acetylcholinesterase inhibitor
DISTIGMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
T940307O7B
Molecule Type:
Small molecule
Molecular Formula:
C22H32N4O4+2
Molecular Weight:
416.52
AlogP:
2.46
PSA:
66.84
HBD:
0.0
HBA:
#RotB:
9.0
Source:
DOPEXAMINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DOPEXAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
0VN909S60Y
Molecule Type:
Small molecule
Molecular Formula:
C22H34Cl2N2O2
Molecular Weight:
429.43
AlogP:
3.62
PSA:
64.52
HBD:
4.0
HBA:
#RotB:
13.0
Source:
EICOSAPENTAENOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
EICOSAPENTAENOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEANUT OIL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PEANUT OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
5TL50QU0W4
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLDINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
POLDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8R92106W2F
Molecule Type:
Small molecule
Molecular Formula:
C21H26NO3+
Molecular Weight:
340.44
AlogP:
2.7
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SULFIRAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SULFIRAM
×
Maximum Phase:
4
First Approval:
None
UNII:
1XHL4Q8P7Y
Molecule Type:
Small molecule
Molecular Formula:
C10H20N2S3
Molecular Weight:
264.49
AlogP:
2.97
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
INDOBUFEN
4
Small molecule
Approved
Unknown
Unknown
Atrial Fibrillation; Thrombosis
Unknown
INDOBUFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
6T9949G4LZ
Molecule Type:
Small molecule
Molecular Formula:
C18H17NO3
Molecular Weight:
295.34
AlogP:
3.43
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TRIMETAZIDINE
4
Small molecule
Approved
Unknown
Unknown
Acute-On-Chronic Liver Failure; Heart Failure; Peripheral Nervous System Diseases; Cardiomyopathy, Hypertrophic; Cardiotoxicity; Diabetic Nephropathies; Hypertension, Pulmonary; Non-alcoholic Fatty Liver Disease; Cardiovascular Diseases
Unknown
TRIMETAZIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
N9A0A0R9S8
Molecule Type:
Small molecule
Molecular Formula:
C14H22N2O3
Molecular Weight:
266.34
AlogP:
1.12
PSA:
42.96
HBD:
1.0
HBA:
#RotB:
5.0
Source:
THENALIDINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity; Pruritus
Histamine H1 receptor antagonist
THENALIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
6U94N2D00F
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2S
Molecular Weight:
286.44
AlogP:
3.85
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
VONOPRAZAN
4
Small molecule
Approved
Unknown
Unknown
Esophagitis; Helicobacter Infections; Gastroesophageal Reflux; Peptic Ulcer
Unknown
VONOPRAZAN
×
Maximum Phase:
4
First Approval:
None
UNII:
1R5L3J156G
Molecule Type:
Small molecule
Molecular Formula:
C17H16FN3O2S
Molecular Weight:
345.4
AlogP:
2.65
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TIOTROPIUM BROMIDE MONOHYDRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TIOTROPIUM BROMIDE MONOHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROPHENOTHANE
4
Small molecule
Approved
Unknown
Unknown
Ectoparasitic Infestations
Unknown
CHLOROPHENOTHANE
×
Maximum Phase:
4
First Approval:
None
UNII:
CIW5S16655
Molecule Type:
Small molecule
Molecular Formula:
C14H9Cl5
Molecular Weight:
354.49
AlogP:
6.5
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ALISKIREN HEMIFUMARATE
4
Small molecule
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
ALISKIREN HEMIFUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISOFLAVONE
4
Small molecule
Approved
Unknown
Unknown
Adenocarcinoma of Lung; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Lung Neoplasms; Kidney Failure, Chronic; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Menopause
Unknown
ISOFLAVONE
×
Maximum Phase:
4
First Approval:
None
UNII:
OVO2KUW8H8
Molecule Type:
Small molecule
Molecular Formula:
C15H10O2
Molecular Weight:
222.24
AlogP:
3.46
PSA:
30.21
HBD:
0.0
HBA:
#RotB:
1.0
Source:
TETRAZEPAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator
TETRAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
FO92091VP8
Molecule Type:
Small molecule
Molecular Formula:
C16H17ClN2O
Molecular Weight:
288.78
AlogP:
3.61
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
1.0
Source:
BENETHAMINE PENICILLIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BENETHAMINE PENICILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
O3S7RWT8R5
Molecule Type:
Small molecule
Molecular Formula:
C31H35N3O4S
Molecular Weight:
545.71
AlogP:
0.86
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PROTIONAMIDE
4
Small molecule
Approved
Unknown
Unknown
Tuberculosis, Pulmonary; Tuberculosis
Unknown
PROTIONAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
76YOO33643
Molecule Type:
Small molecule
Molecular Formula:
C9H12N2S
Molecular Weight:
180.28
AlogP:
1.67
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DEXKETOPROFEN
4
Small molecule
Approved
Unknown
Unknown
Low Back Pain; Pain; Wounds and Injuries; Arthralgia; Myalgia; Rheumatic Diseases
Cyclooxygenase inhibitor
DEXKETOPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
6KD9E78X68
Molecule Type:
Small molecule
Molecular Formula:
C16H14O3
Molecular Weight:
254.29
AlogP:
3.11
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ACECLOFENAC
4
Small molecule
Approved
Unknown
Unknown
Pulpitis; Arthralgia; Arthritis, Rheumatoid; Myalgia; Osteoarthritis; Rheumatic Diseases; Spondylitis
Cyclooxygenase-2 inhibitor
ACECLOFENAC
×
Maximum Phase:
4
First Approval:
None
UNII:
RPK779R03H
Molecule Type:
Small molecule
Molecular Formula:
C16H13Cl2NO4
Molecular Weight:
354.19
AlogP:
3.91
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
6.0
Source:
RIMITEROL HYDROBROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
RIMITEROL HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
I29DRR8S3R
Molecule Type:
Small molecule
Molecular Formula:
C12H18BrNO3
Molecular Weight:
304.18
AlogP:
1.27
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
2.0
Source:
L-NMMA
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
L-NMMA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-SERINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
D-SERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TACALCITOL
4
Small molecule
Approved
Unknown
Unknown
Psoriasis
Unknown
TACALCITOL
×
Maximum Phase:
4
First Approval:
None
UNII:
C2W72OJ5ZU
Molecule Type:
Small molecule
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
AlogP:
5.56
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AMITRIPTYLINOXIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
AMITRIPTYLINOXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
TYR2U59WMA
Molecule Type:
Small molecule
Molecular Formula:
C20H23NO
Molecular Weight:
293.41
AlogP:
4.18
PSA:
23.06
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ACEFYLLINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACEFYLLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
M494UE2YEP
Molecule Type:
Small molecule
Molecular Formula:
C9H10N4O4
Molecular Weight:
238.2
AlogP:
-1.48
PSA:
99.12
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CINOXATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CINOXATE
×
Maximum Phase:
4
First Approval:
None
UNII:
5437O7N5BH
Molecule Type:
Small molecule
Molecular Formula:
C14H18O4
Molecular Weight:
250.29
AlogP:
2.29
PSA:
44.76
HBD:
0.0
HBA:
#RotB:
7.0
Source:
RIMITEROL
4
Small molecule
Approved
Unknown
Unknown
Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
RIMITEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
26GIW6ZLPH
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO3
Molecular Weight:
223.27
AlogP:
1.27
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ROXITHROMYCIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Unknown
ROXITHROMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
21KOF230FA
Molecule Type:
Small molecule
Molecular Formula:
C41H76N2O15
Molecular Weight:
837.06
AlogP:
2.21
PSA:
216.89
HBD:
5.0
HBA:
#RotB:
13.0
Source:
IPRAGLIFLOZIN
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus
Sodium/glucose cotransporter 2 inhibitor
IPRAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
None
UNII:
3N2N8OOR7X
Molecule Type:
Small molecule
Molecular Formula:
C21H21FO5S
Molecular Weight:
404.46
AlogP:
2.15
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
4.0
Source:
BENZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BENZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
8SKN0B0MIM
Molecule Type:
Small molecule
Molecular Formula:
C7H6O2
Molecular Weight:
122.12
AlogP:
1.38
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ANTIPYRINE
4
Small molecule
Approved
Unknown
Unknown
Asthma; Otitis Media; Dysmenorrhea; Fever; Pain
Cyclooxygenase-1 inhibitor
ANTIPYRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
T3CHA1B51H
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O
Molecular Weight:
188.23
AlogP:
1.48
PSA:
26.93
HBD:
0.0
HBA:
#RotB:
1.0
Source:
GLIBORNURIDE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus
Unknown
GLIBORNURIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
VP83E7434R
Molecule Type:
Small molecule
Molecular Formula:
C18H26N2O4S
Molecular Weight:
366.48
AlogP:
2.17
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
3.0
Source:
1
2
…
172
173
174
175
176
177
178
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA